Literature DB >> 8286192

Human papillomavirus and invasive cervical cancer in Brazil.

J Eluf-Neto1, M Booth, N Muñoz, F X Bosch, C J Meijer, J M Walboomers.   

Abstract

A hospital-based case-control study was undertaken to examine the role of human papillomavirus (HPV) in the development of invasive cervical cancer in Brazil. The study included 199 histologically confirmed incident cases and 225 age-frequency-matched controls selected from a wide range of diagnostic categories. A polymerase chain reaction technique was used to detect HPV DNA in cervical specimens collected with spatula and brush. HPV DNA was detected in 84% of the cases compared with 17% of controls. Grouping HPV types 16, 18, 31 and 33, 66% of the cases were positive compared with only 6% of the controls. In addition to HPV, number of sexual partners, early age at first intercourse, parity and duration of oral contraceptive use were significantly associated with an increased risk of cervical cancer. A history of previous Papanicolaou smears was significantly associated with a decreased risk. After adjustment, only presence of HPV DNA, parity and history of previous smears remained as independent risk factors. The adjusted odds ratios of cervical cancer associated with HPV 16, 18, 31, and 33 was 69.7 (95% confidence interval 28.7-169.6) and with unidentified types was 12.0 (5.1-28.5). The very high risks found in this study further implicate this virus in the aetiology of cervical cancer.

Entities:  

Keywords:  Americas; Brazil; Cancer; Cervical Cancer; Demographic Factors; Developing Countries; Diseases; Examinations And Diagnoses; Hpv; Laboratory Examinations And Diagnoses; Latin America; Neoplasms; Population; Population Characteristics; Research Report; South America; Urban Population; Viral Diseases

Mesh:

Substances:

Year:  1994        PMID: 8286192      PMCID: PMC1968795          DOI: 10.1038/bjc.1994.18

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  27 in total

Review 1.  Screening for cancer of the cervix.

Authors:  N E Day
Journal:  J Epidemiol Community Health       Date:  1989-06       Impact factor: 3.710

2.  Rapid detection of human papillomavirus in cervical scrapes by combined general primer-mediated and type-specific polymerase chain reaction.

Authors:  A J van den Brule; C J Meijer; V Bakels; P Kenemans; J M Walboomers
Journal:  J Clin Microbiol       Date:  1990-12       Impact factor: 5.948

3.  Invasive cervical cancer and smoking in Latin America.

Authors:  R Herrero; L A Brinton; W C Reeves; M M Brenes; F Tenorio; R C de Britton; E Gaitan; M Garcia; W E Rawls
Journal:  J Natl Cancer Inst       Date:  1989-02-01       Impact factor: 13.506

4.  Risk factors for cervical human papillomavirus and herpes simplex virus infections in Greenland and Denmark: a population-based study.

Authors:  S K Kjaer; G Engholm; C Teisen; B J Haugaard; E Lynge; R B Christensen; K A Møller; H Jensen; P Poll; B F Vestergaard
Journal:  Am J Epidemiol       Date:  1990-04       Impact factor: 4.897

5.  The use of general primers in the polymerase chain reaction permits the detection of a broad spectrum of human papillomavirus genotypes.

Authors:  P J Snijders; A J van den Brule; H F Schrijnemakers; G Snow; C J Meijer; J M Walboomers
Journal:  J Gen Virol       Date:  1990-01       Impact factor: 3.891

6.  Human papillomavirus infection and cervical cancer in Latin America.

Authors:  W C Reeves; L A Brinton; M García; M M Brenes; R Herrero; E Gaitán; F Tenorio; R C de Britton; W E Rawls
Journal:  N Engl J Med       Date:  1989-06-01       Impact factor: 91.245

7.  Use of anticontamination primers in the polymerase chain reaction for the detection of human papilloma virus genotypes in cervical scrapes and biopsies.

Authors:  A J van den Brule; E C Claas; M du Maine; W J Melchers; T Helmerhorst; W G Quint; J Lindeman; C J Meijer; J M Walboomers
Journal:  J Med Virol       Date:  1989-09       Impact factor: 2.327

8.  Human papillomavirus types 16 and 33, herpes simplex virus type 2 and other risk factors for cervical cancer in Sichuan Province, China.

Authors:  H Q Peng; S L Liu; V Mann; T Rohan; W Rawls
Journal:  Int J Cancer       Date:  1991-03-12       Impact factor: 7.396

9.  Parity as a risk factor for cervical cancer.

Authors:  L A Brinton; W C Reeves; M M Brenes; R Herrero; R C de Britton; E Gaitan; F Tenorio; M Garcia; W E Rawls
Journal:  Am J Epidemiol       Date:  1989-09       Impact factor: 4.897

10.  Association between poor prognosis in early-stage invasive cervical carcinomas and non-detection of HPV DNA.

Authors:  G Riou; M Favre; D Jeannel; J Bourhis; V Le Doussal; G Orth
Journal:  Lancet       Date:  1990-05-19       Impact factor: 79.321

View more
  46 in total

1.  Human papillomavirus type 16 sequence variation in cervical cancers: a worldwide perspective.

Authors:  T Yamada; M M Manos; J Peto; C E Greer; N Munoz; F X Bosch; C M Wheeler
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

2.  Is oral contraceptive associated with genital warts?

Authors:  J D Ross
Journal:  Genitourin Med       Date:  1996-10

Review 3.  Cost-effective policies for cervical cancer screening. An international review.

Authors:  M C Fahs; S B Plichta; J S Mandelblatt
Journal:  Pharmacoeconomics       Date:  1996-03       Impact factor: 4.981

Review 4.  The causal relation between human papillomavirus and cervical cancer.

Authors:  F X Bosch; A Lorincz; N Muñoz; C J L M Meijer; K V Shah
Journal:  J Clin Pathol       Date:  2002-04       Impact factor: 3.411

5.  Intratype variation in 12 human papillomavirus types: a worldwide perspective.

Authors:  A C Stewart; A M Eriksson; M M Manos; N Muñoz; F X Bosch; J Peto; C M Wheeler
Journal:  J Virol       Date:  1996-05       Impact factor: 5.103

6.  Invited commentary: Human papillomavirus infection and risk of cervical precancer--using the right methods to answer the right questions.

Authors:  Eduardo L Franco; Joseph Tota
Journal:  Am J Epidemiol       Date:  2009-12-10       Impact factor: 4.897

7.  Prevalence of human papillomavirus in archival samples obtained from patients with cervical pre-malignant and malignant lesions from Northeast Brazil.

Authors:  José V Fernandes; Rosely V Meissner; Maria Gf Carvalho; Thales Aam Fernandes; Paulo Rm Azevedo; João S Sobrinho; José Cm Prado; Luisa L Villa
Journal:  BMC Res Notes       Date:  2010-04-08

8.  Prevalence of HPV infection among Greek women attending a gynecological outpatient clinic.

Authors:  Petroula Stamataki; Athanasia Papazafiropoulou; Ioannis Elefsiniotis; Margarita Giannakopoulou; Hero Brokalaki; Eleni Apostolopoulou; Pavlos Sarafis; George Saroglou
Journal:  BMC Infect Dis       Date:  2010-02-15       Impact factor: 3.090

Review 9.  Nutrition and cervical neoplasia.

Authors:  N Potischman; L A Brinton
Journal:  Cancer Causes Control       Date:  1996-01       Impact factor: 2.506

10.  Differences in the risk of cervical cancer and human papillomavirus infection by education level.

Authors:  S Franceschi; M Plummer; G Clifford; S de Sanjose; X Bosch; R Herrero; N Muñoz; S Vaccarella
Journal:  Br J Cancer       Date:  2009-08-04       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.